Mantle Cell Lymphoma
Efbemalenograstim has been approved by the FDA to combat infections in adults being treated for nonmyeloid cancers.
FDA’s ODAC committee pressed for resolution on whether 2 lymphoma drugs, long on the U.S. market, actually deliver significant benefits to...
Dr. Christopher Flowers, a prominent African American oncologist with expertise in blood cancer and health disparity research, heads a key...
From the Journals
The group’s new study evaluation tool, the ESMO-MCBS:H, is aimed at helping doctors and others determine the benefit of new blood cancer therapies...
Only a small percentage of eligible patients participate in clinical trials in the first place, and very few come from racial and ethnic minority...
Few patients with cancer have access to psycho-oncologic support.
Information from germline genetic testing could affect a patient’s cancer care.
Only 2%-3% of practicing oncologists are Black or Hispanic/Latino, says Yale Cancer Center doctor.